CONCLUSION
With the increase of extended-spectrum antimicrobial application, AB is
rapidly evolving toward multidrug resistance. In our study multidrug
resistance AB rate was high. Nosocomial infections caused by AB are very
difficult to treat. AB infections are associated with high high
morbidity and mortality rate.Knowing the risk factors that indicate
mortality in such patients and ensuring early diagnosis are of critical
importance with respect to prognosis. Starting appropriate therapy by
making the right decisions regarding the severity of acute and
underlying conditions will have favorable effects on the management of
A. baumannii bacteremia.
In conclusion, the risk factors that indicate mortality in patients and
these patients are closely watched and bacterial early determination of
the importance of the prognosis of the patient bears. Severe acute
illness and underlying disease start appropriate treatment by making the
right decision, the effect will be better in the A. baumannii bacteria.
Also avoid unnecessary antibiotic treatment and prophylaxis and can be
controlled as strict infection control measures abolition of risk
factors, originating from A. Baumannii reduce possible bactericides and
related deaths.
REFERENCES
1. Del Mar Tomas M, Cartelle M, Pertega S, Beceiro A, Llinares P, Canle
D, Molina F, Villanueva R, Cisneros JM, Bou G. Hospital outbreak caused
by a carbapenem-resistant strain of Acinetobacter baumannii: patient
prognosis and risk factors for colonisation and infection. Clin
Microbiol Infect 2005;11: 540-546.
2. Dettori M, Piana A, Deriu MG, Lo Curto P, Cossu A, Musumeci R,
Cocuzza C, Astone V, Contu MA, Sotgiu G . Outbreak of
multidrug-resistant Acinetobacter baumannii in an intensive care unit.
New Microbiol 2014; 37: 185- 191.
3. Ye D, Shan J, Huang Y, Li J, Li C, Liu X, He W, Li Y, Mao P. A
gloves-associated outbreak of imipenem-resistant Acinetobacter baumannii
in an intensive care unit in Guangdong, China. BMC Infect Dis.2015; 15:
179.
4. Dalla-Costa LM, Coelho JM, Souza HA, Castro ME, Stier CJ, Bragagnolo
KL, Rea-Neto A, Penteado-Filho SR, Livermore DM, Woodford N . Outbreak
of carbapenem-resistant Acinetobacter baumannii producing the OXA-23
enzyme in Curitiba, Brazil. J Clin Microbiol 2003;41: 3403-3406.
5. Teo J, Lim TP, Hsu LY, Tan TY, Sasikala S, Hon PY, Kwa AL,
Apisarnthanarak A .Extensively drug-resistant Acinetobacter baumannii in
a Thai hospital: a molecular epidemiologic analysis and identification
of bactericidal Polymyxin B-based combinations. Antimicrob Resist Infect
Control 2015;4:2.
6. Markogiannakis A, Fildisis G, Tsiplakou S, Ikonomidis A, Koutsoukou
A, Pournaras S, Manolis EN, Baltopoulos G, Tsakris A .Cross-transmission
of multidrug-resistant Acinetobacter baumannii clonal strains causing
episodes of sepsis in a trauma intensive care unit. Infect Control Hosp
Epidemiol 2008;29: 410-417.
7. Senok A, Garaween G, Raji A, Khubnani H, Kim Sing G, Shibl A .
Genetic relatedness of clinical and environmental Acinetobacter baumanii
isolates from an intensive care unit outbreak. J Infect Dev Ctries
2015;9: 665-669.
8. Huttner A, Harbarth S, Carlet J, Cosgrove S, Goossens H, Holmes A,
Jarlier V, Voss A, Pittet D. Antimicrobial resistance: a global view
from the 2013 World Healthcare-Associated Infections Forum. Antimicrob
Resist Infect Control. 2013;2:2-31.
9. Samuel S, Kayode O, Musa O, Nwigwe G, Aboderin A, Salami T, Taiwo S.
Nosocomial infections and the challenges of control in developing
countries. Afr J Clin Exp Microbiol. 2010;11:102-9.
10. Hasanin A, Eladawy A, Mohamed H, Salah Y, Lotfy A, Mostafa H, Ghaith
D, Mukhtar A. Prevalence of extensively drug-resistant gram negative
bacilli in surgical intensive care in Egypt. Pan Afr Med J.
2014;19:177,4307.
11. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of
carbapenem-resistant A. baumannii. Br Soc Antimicrob Chemother.
2010;428.
12. Chang YJ, Yeh ML, Li YC, Hsu CY, Lin CC, Hsu M-S, Chiu WT.
Predicting hospital-acquired infections by scoring system with simple
parameters. PLoS One. 2011;6:1-11.
13. Simonetti AF, Viasus D, Garcia-Vidal C, Carratalà J. Management of
community-acquired pneumonia in older adults. Ther Adv Infect Dis.
2014;2:3-16.
14. Hill R, Paulus S, Dey P, Hurley MA, Carter B. Is undernutrition
prognostic of infection complications in children undergoing surgery? A
systematic review. J Hosp Infect. 2016;93:12-21.
15. Gyansa-Lutterodt M, Afriyie D, Asare G, Amponsah S, Abutiate H,
Darko D. Antimicrobial use and susceptibility pattern of uropathogens
associated with urinary tract infections at the Ghana Police Hospital.
Glob J Pharmacol. 2014;8:306-15
16. Ghaith DM, Hassan RM, Hasanin AM. Rapid identifcation of nosocomial
A. baumannii isolated from a surgical intensive care unit in Egypt. Ann
Saudi Med. 2015;36(5):440-4.
17. Hasanin A, Mukhtar A, El-Adawy A, Elazizi H, Lotfyn A, Nassar H,
Ghaith D. Ventilator associated pneumonia caused by extensive-drug
resistant Acinetobacter species: colistin is the remaining choice. Egypt
J Anaesth. 2016; 3-4
18. Lee HY, Chen CL, Wu SR, Huang CW, Chiu CH. Risk factors and outcome
analysis of Acinetobacter baumannii complex bacteremia in critical
patients. Crit Care Med 2014;42:1081-1088.
19. Falagas ME, Kopterides P. Risk factors for the isolation of
multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa:
a systematic review of the literature. J Hosp Infect 2006; 64:7-15.
20. Zhou HY, Yuan Z, Du YP. Prior use of four invasive procedures
increases the risk of Acinetobacter baumannii nosocomial bacteremia
among patients in intensive care units: a systematic review and
meta-analysis. Int J Infect Dis 2014;22:25-30.
21. Katsaragakis S, Markogiannakis H, Samara E, et al. predictors of
mortality of Acinetobacter baumannii infections: A 2-year prospective
study in a Greek surgical intensive care unit. Am J Infect Control 2010;
38: 631-5.
22. Prates CG, Martıns AF,Supertı SV, Lopes FS, Ramos F, Cantarellı VV,
et al. Risk factors for 30-day mortality in patients with
carbapenem-resistant Acinetobacter baumannii during an outbreak in an
intensive care unit. Epidemiol Infect 2011;139:411-8
23. Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to
Acinetobacter baumannii: clinical features, epidemiology, and predictors
of mortality. Medicine (Baltimore) 1995;74:340-9.
24. Cisneros JM, Reyes MJ, Pacho´n J, Becerril B, Caballero FJ,
Garcı´aGarmendı´a JL, et al. Bacteremia due to Acinetobacter baumannii:
epidemiology, clinical findings, and prognostic features. Clin Infect
Dis 1996; 22:1026-32.
25. Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P, et al.
Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk
factors and prognosis. Clin Infect Dis 1995; 20:790-6.
25. Go´mez J, Simarro E, Ban˜os V, Requena L, Ruiz J, Garcı´a F, et al.
Sixyear prospective study of risk and prognostic factors in patients
with nosocomial sepsis caused by Acinetobacter baumannii. Eur J Clin
Microbiol Infect Dis 1999; 18: 358-61.
27. Cisneros JM, Rodriguez-Ban˜o J. Nosocomial bacteremia due to
Acinetobacter baumannii: epidemiology, clinical features and treatment.
Clin Microbiol Infect 2002;8:687-93.
28. Reina R, Estenssoro E, Sa´enz G, Canales HS, Gonzalvo R, Vidal G, et
al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas
infections: a prospective cohort study. Intensive Care Med 2005; 31:
1058-65.
29. Chen HP, Chen TL, Lai CH, Fung CP, Wong WW, Yu KW, et al. Predictors
of mortality in Acinetobacter baumannii bacteremia. J Microbiol Immunol
Infect 2005;38:127-36.
30. del Mar Tomas M, Cartelle M, Pertega S, Beceiro A, Llinares P, Canle
D, et al. Hospital outbreak caused by a carbapenem-resistant strain of
Acinetobacter baumannii: patient prognosis and risk factors for
colonisation and infection. Clin Microbiol Infect 2005;11:540-6.
31. Choi JY, Park YS, Kim CO, Park YS, Yoon HJ, Shin SY, et al.
Mortality risk factors of Acinetobacter baumannii bacteraemia. Intern
Med J 2005; 35:599-603.
32. Garnacho-Montero J, Ortiz-Leyba C, Ferna´ndez-Hinojosa E, Aldabo´-
Palla´s T, Cayuela A, Marquez-Va´caro JA, et al. Acinetobacter baumannii
ventilator-associated pneumonia: epidemiological and clinical findings.
Intensive Care Med 2005; 31:649-55.
33. Kaul R, Burt JA, Cork L, Dedier H, Garcia M, Kennedy C, et al.
Investigation of a multiyear multiple critical care unit outbreak due to
relatively drug-sensitive Acinetobacter baumannii: risk factors and
attributable mortality. J Infect Dis 1996; 174:1279-87.
34. Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas
ME. Colistin treatment in patients with ICU-acquired infections caused
by multiresistant gram-negative bacteria: the renaissance of an old
antibiotic. Clin Microbiol Infect 2005; 11:115-21.
25. Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans
E, Wilmer A, et al. Thrombocytopenia and prognosis in intensive care.
Crit Care Med 2000; 28:1871-6.